Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

South America Preclinical Imaging Market

ID: MRFR/MED/48500-HCR
200 Pages
Vikita Thakur
Last Updated: April 06, 2026

South America Preclinical Imaging Market Research Report By Product (Optical Imaging, Nuclear Imaging, Micro-MRI, Micro-Ultrasound, Micro-CT, Photoacoustic Imaging System), By Distribution Channel (Optical, Nuclear, CT Contrast Agents, MRI Contrast Agents) and By Regional (Brazil, Mexico, Argentina, Rest of South America) - Growth & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

South America Preclinical Imaging Market Infographic
Purchase Options
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Pharmaceutical, BY Product (USD Million)
  49.     4.1.1 Optical Imaging
  50.     4.1.2 Nuclear Imaging
  51.     4.1.3 Micro-MRI
  52.     4.1.4 Micro-Ultrasound
  53.     4.1.5 Micro-CT
  54.     4.1.6 Photoacoustic Imaging Systems
  55.   4.2 Pharmaceutical, BY Reagents (USD Million)
  56.     4.2.1 Optical
  57.     4.2.2 Nuclear
  58.     4.2.3 CT Contrast Agents
  59.     4.2.4 MRI Contrast Agents
  60. 5 SECTION V: COMPETITIVE ANALYSIS
  61.   5.1 Competitive Landscape
  62.     5.1.1 Overview
  63.     5.1.2 Competitive Analysis
  64.     5.1.3 Market share Analysis
  65.     5.1.4 Major Growth Strategy in the Pharmaceutical
  66.     5.1.5 Competitive Benchmarking
  67.     5.1.6 Leading Players in Terms of Number of Developments in the Pharmaceutical
  68.     5.1.7 Key developments and growth strategies
  69.       5.1.7.1 New Product Launch/Service Deployment
  70.       5.1.7.2 Merger & Acquisitions
  71.       5.1.7.3 Joint Ventures
  72.     5.1.8 Major Players Financial Matrix
  73.       5.1.8.1 Sales and Operating Income
  74.       5.1.8.2 Major Players R&D Expenditure. 2023
  75.   5.2 Company Profiles
  76.     5.2.1 Bruker Corporation (US)
  77.       5.2.1.1 Financial Overview
  78.       5.2.1.2 Products Offered
  79.       5.2.1.3 Key Developments
  80.       5.2.1.4 SWOT Analysis
  81.       5.2.1.5 Key Strategies
  82.     5.2.2 PerkinElmer Inc. (US)
  83.       5.2.2.1 Financial Overview
  84.       5.2.2.2 Products Offered
  85.       5.2.2.3 Key Developments
  86.       5.2.2.4 SWOT Analysis
  87.       5.2.2.5 Key Strategies
  88.     5.2.3 Siemens Healthineers (DE)
  89.       5.2.3.1 Financial Overview
  90.       5.2.3.2 Products Offered
  91.       5.2.3.3 Key Developments
  92.       5.2.3.4 SWOT Analysis
  93.       5.2.3.5 Key Strategies
  94.     5.2.4 GE Healthcare (US)
  95.       5.2.4.1 Financial Overview
  96.       5.2.4.2 Products Offered
  97.       5.2.4.3 Key Developments
  98.       5.2.4.4 SWOT Analysis
  99.       5.2.4.5 Key Strategies
  100.     5.2.5 Philips Healthcare (NL)
  101.       5.2.5.1 Financial Overview
  102.       5.2.5.2 Products Offered
  103.       5.2.5.3 Key Developments
  104.       5.2.5.4 SWOT Analysis
  105.       5.2.5.5 Key Strategies
  106.     5.2.6 Thermo Fisher Scientific Inc. (US)
  107.       5.2.6.1 Financial Overview
  108.       5.2.6.2 Products Offered
  109.       5.2.6.3 Key Developments
  110.       5.2.6.4 SWOT Analysis
  111.       5.2.6.5 Key Strategies
  112.     5.2.7 Miltenyi Biotec (DE)
  113.       5.2.7.1 Financial Overview
  114.       5.2.7.2 Products Offered
  115.       5.2.7.3 Key Developments
  116.       5.2.7.4 SWOT Analysis
  117.       5.2.7.5 Key Strategies
  118.     5.2.8 Fujifilm Holdings Corporation (JP)
  119.       5.2.8.1 Financial Overview
  120.       5.2.8.2 Products Offered
  121.       5.2.8.3 Key Developments
  122.       5.2.8.4 SWOT Analysis
  123.       5.2.8.5 Key Strategies
  124.     5.2.9 Mediso Medical Imaging Systems (HU)
  125.       5.2.9.1 Financial Overview
  126.       5.2.9.2 Products Offered
  127.       5.2.9.3 Key Developments
  128.       5.2.9.4 SWOT Analysis
  129.       5.2.9.5 Key Strategies
  130.   5.3 Appendix
  131.     5.3.1 References
  132.     5.3.2 Related Reports
  133. 6 LIST OF FIGURES
  134.   6.1 MARKET SYNOPSIS
  135.   6.2 SOUTH AMERICA MARKET ANALYSIS BY PRODUCT
  136.   6.3 SOUTH AMERICA MARKET ANALYSIS BY REAGENTS
  137.   6.4 KEY BUYING CRITERIA OF PHARMACEUTICAL
  138.   6.5 RESEARCH PROCESS OF MRFR
  139.   6.6 DRO ANALYSIS OF PHARMACEUTICAL
  140.   6.7 DRIVERS IMPACT ANALYSIS: PHARMACEUTICAL
  141.   6.8 RESTRAINTS IMPACT ANALYSIS: PHARMACEUTICAL
  142.   6.9 SUPPLY / VALUE CHAIN: PHARMACEUTICAL
  143.   6.10 PHARMACEUTICAL, BY PRODUCT, 2024 (% SHARE)
  144.   6.11 PHARMACEUTICAL, BY PRODUCT, 2024 TO 2035 (USD Million)
  145.   6.12 PHARMACEUTICAL, BY REAGENTS, 2024 (% SHARE)
  146.   6.13 PHARMACEUTICAL, BY REAGENTS, 2024 TO 2035 (USD Million)
  147.   6.14 BENCHMARKING OF MAJOR COMPETITORS
  148. 7 LIST OF TABLES
  149.   7.1 LIST OF ASSUMPTIONS
  150.     7.1.1
  151.   7.2 South America MARKET SIZE ESTIMATES; FORECAST
  152.     7.2.1 BY PRODUCT, 2025-2035 (USD Million)
  153.     7.2.2 BY REAGENTS, 2025-2035 (USD Million)
  154.   7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  155.     7.3.1
  156.   7.4 ACQUISITION/PARTNERSHIP
  157.     7.4.1

South America Pharmaceutical Market Segmentation

Pharmaceutical By Product (USD Million, 2025-2035)

  • Optical Imaging
  • Nuclear Imaging
  • Micro-MRI
  • Micro-Ultrasound
  • Micro-CT
  • Photoacoustic Imaging Systems

Pharmaceutical By Reagents (USD Million, 2025-2035)

  • Optical
  • Nuclear
  • CT Contrast Agents
  • MRI Contrast Agents

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions